CATALOGO DEI PRODOTTI DELLA RICERCA

Mariotto, Sara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.810
EU - Europa 2.328
AS - Asia 1.579
AF - Africa 34
OC - Oceania 25
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.794
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.802
CN - Cina 918
SG - Singapore 455
GB - Regno Unito 445
IT - Italia 355
RU - Federazione Russa 330
IE - Irlanda 290
SE - Svezia 285
FR - Francia 259
DE - Germania 176
FI - Finlandia 88
VN - Vietnam 61
ID - Indonesia 34
KR - Corea 29
TG - Togo 29
UA - Ucraina 29
AU - Australia 24
IR - Iran 23
BE - Belgio 21
IN - India 17
HK - Hong Kong 13
JP - Giappone 13
BR - Brasile 9
ES - Italia 9
NL - Olanda 9
CA - Canada 5
CL - Cile 4
LU - Lussemburgo 4
RO - Romania 4
AR - Argentina 3
BG - Bulgaria 3
CZ - Repubblica Ceca 3
LT - Lituania 3
TR - Turchia 3
AT - Austria 2
CH - Svizzera 2
HU - Ungheria 2
IL - Israele 2
SA - Arabia Saudita 2
TW - Taiwan 2
ZM - Zambia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
IM - Isola di Man 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PL - Polonia 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 6.794
Salva come PNG Salva come JPEG
Città #
Chandler 674
Southend 403
Singapore 383
Ashburn 288
Dublin 276
Beijing 210
Woodbridge 145
Jacksonville 127
Verona 121
New York 99
Lawrence 96
Princeton 96
Ann Arbor 93
Wilmington 83
Jinan 69
Dearborn 66
Houston 55
Shenyang 54
Redmond 53
Helsinki 52
Sindelfingen 52
Nanjing 51
Hebei 43
Washington 37
Dong Ket 36
Jakarta 34
Lomé 29
Milan 28
Tianjin 28
Ningbo 27
Seattle 27
Seoul 27
Boardman 26
Adelaide 22
Changsha 22
Guangzhou 22
Hangzhou 22
Brussels 21
Falls Church 21
Nanchang 20
Bologna 19
Taiyuan 19
Zhengzhou 19
Kent 18
Los Angeles 18
Haikou 17
Chicago 16
Dallas 16
Moscow 16
Redwood City 16
Santa Clara 16
Norwalk 15
Taizhou 15
Bloomsbury 13
Fairfield 11
Hong Kong 11
Lappeenranta 11
Menlo Park 11
Dongguan 10
Jiaxing 10
Lanzhou 9
Florence 8
Hefei 8
Lancaster 8
Fuzhou 7
Tokyo 7
Valencia 7
Clearwater 6
Paris 6
San Diego 6
Udine 6
Bussolengo 5
Cambridge 5
Phoenix 5
Shanghai 5
Shenzhen 5
Yicheng 5
Brescia 4
Cagliari 4
Catanzaro 4
Düsseldorf 4
Frankfurt am Main 4
Kochi 4
Padova 4
Tappahannock 4
Treviso 4
Amsterdam 3
Bari 3
Buenos Aires 3
Carpi 3
Edinburgh 3
Fort Worth 3
Göttingen 3
Hyderabad 3
London 3
Riva 3
San Francisco 3
Sant'Ambrogio di Valpolicella 3
Sofia 3
Wuhan 3
Totale 4.521
Salva come PNG Salva come JPEG
Nome #
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 144
Cyclooxygenase 2, toll-like receptor 4 and interleukin 1beta mRNA expression in atherosclerotic plaques of type 2 diabetic patients. 126
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian Consensus Conference on Pain in Neurorehabilitation 125
Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. 117
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 115
Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy 107
Cauda equina syndrome caused by lumbosacral epidural lipomatosis. A case report. 107
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 106
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management 102
Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 101
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 97
Neurosyphilis manifesting with rapidly progressive dementia: report of three cases. 96
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 96
HCV-related nervous system disorders. 94
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 89
Brentuximab vedotin: axonal microtubule's Apollyon 88
l-dopa-induced off: functional overlay in Parkinson disease 85
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 83
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 83
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 82
Persistence of anti-NMDAR antibodies in CSF after recovery from autoimmune encephalitis 81
MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome 81
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 80
Sural nerve biopsy: current role and comparison with serum neurofilament light chain levels 77
Cerebrospinal fluid analysis and the determination of oligoclonal bands 76
Neurofilament light chain levels in patients with antibodies to myelin oligodendrocyte glycoprotein (MOG-Abs) 75
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? 75
Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder 74
The original histological slides of Camillo Golgi and his discoveries on neuronal structure 74
Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD) 73
Infectious neuropathies 72
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies 72
Clinical Neuropathology image 1-2018: Golgi silver staining, the black reaction 70
Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy 70
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 69
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 68
Gender disparity in editorial boards of journals in neurology 68
Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors? 68
Review of West Nile virus epidemiology in Italy and report of a case of West Nile virus encephalitis. 67
Brentuximab vedotin-induced peripheral neuropathy: looking at microtubules 67
Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status 65
Antibodies to MOG in CSF only: pathological findings support the diagnostic value 65
Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder 65
Sporadic Creutzfeldt-Jakob disease: prion pathology in medulla oblongata-possible routes of infection and host susceptibility. 64
Acute cervical longitudinally extensive transverse myelitis in a child with Lipopolysaccharide-Responsive-Beige-Like-Anchor-Protein (LRBA) deficiency: a new complication of a rare disease 64
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 63
GABA(A) receptor autoimmunity after alemtuzumab treatment for multiple sclerosis 63
Inter-center agreement in the interpretation of oligoclonal bands 62
Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings 61
Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study 61
Hypothalamic-Bulbar MRI hyperintensity in Anti-IgLON5 disease with serum-restricted antibodies: a case report and systematic review of literature 61
Nervous system: subclinical target of SARS-CoV-2 infection 60
Brain stimulation as a therapeutic tool in Amyotrophic Lateral Sclerosis: current status and interaction with mechanisms of altered cortical excitability 59
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 59
Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens 58
HCV-related central and peripheral nervous system demyelinating disorders. 56
Lymphomatosis cerebri and anti-NMDAR antibodies: A unique constellation 56
Autoimmune encephalitis: a retrospective monocentric experience 56
Diagnostics of dysimmune peripheral neuropathies 55
Anti-MOG-associated demyelinating disorders: two sides of the same coin 55
Exposure to TNF inhibitors is rare at MOGAD presentation 55
Oligoclonal bands: clinical utility and interpretation cues 55
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series 55
The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis 54
Diagnostics of paraneoplastic neurological syndromes 54
Mechanisms of nerve damage in neuropathies associated with hematological diseases: lesson from nerve biopsies 53
Diagnostics of anti-MAG antibody polyneuropathy 52
Distinct serum and cerebrospinal fluid cytokine and chemokine profiles in autoantibody-associated demyelinating diseases 52
NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders 52
Serum neurofilament to Magnetic Resonance Imaging lesion area ratio differentiates spinal cord infarction from acute myelitis 51
Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers 49
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 49
Serum neurofilament light chain studies in neurological disorders, hints for interpretation 47
Superior diagnostic performance of reduced-FOV DWI versus conventional DWI MRI in anti-NMDAR encephalitis 47
Ophthalmoparesis mimicking myasthenia gravis as acute manifestation of Hashimoto’s encephalopathy 47
Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel-induced peripheral neurotoxicity in breast cancer patients 47
Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 47
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis 47
HCV RNA genomic sequences and HCV-E2 glycoprotein in sural nerve biopsies from hcv-infected patients with peripheral neuropathy 46
Serum neurofilament light chain levels as biomarker of paclitaxel-induced cognitive impairment in patients with breast cancer: a prospective study 44
Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations 42
Peripheral neuropathies during the COVID-19 pandemic: is there a relation? 41
Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma 40
Conventional brain MRI features distinguishing limbic encephalitis from mesial temporal glioma 38
Serum and cerebrospinal fluid biomarkers in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disease 38
Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders 37
Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers 36
Peripheral neuropathy and central nervous system involvement in cryoglobulinemia 36
Is there a correlation between MOGAD and SARS-CoV-2 infection? 36
Prevalence, incidence, and season distribution of MOG antibody-associated disease in the province of Verona, Italy 35
Investigating paraneoplastic aquaporin-4 positive neuromyelitis optica spectrum disorder through a data-driven approach 34
Differential binding of autoantibodies to MOG isoforms in inflammatory demyelinating diseases 34
Treatment options in refractory autoimmune encephalitis 33
GAD65 autoimmunity after treatment with nivolumab: a multifocal presentation 33
Neurofilament light chain: a promising diagnostic biomarker for functional motor disorders 31
COVID-19 impact on consecutive neurological patients admitted to the emergency department 31
Treatment of myelin oligodendrocyte glycoprotein antibody associated disease with subcutaneous immune globulin 31
Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study 30
Non-demyelinating disorders mimicking and misdiagnosed as NMOSD, a literature review 29
Autoimmune encephalitis misdiagnosis and mimics 28
Totale 6.404
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.272
article - articoli 30.577
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 251
patent - brevetti 0
selected - selezionate 0
volume - volumi 444
Totale 62.544
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020500 0 0 0 0 105 54 121 14 28 67 39 72
2020/2021679 124 74 32 81 67 61 27 17 45 9 73 69
2021/2022839 54 260 2 114 19 32 14 36 31 37 70 170
2022/20231.896 112 186 156 334 141 458 23 129 225 33 61 38
2023/20241.257 47 79 135 135 109 299 55 76 20 68 166 68
2024/20251.087 147 196 118 487 139 0 0 0 0 0 0 0
Totale 7.039